Insiders · Profile

Dawkins Keith D

EVP, Global Chief Med. Off. at Boston Scientific. Filing since 21 Nov 2013. CIK 0001492253

Company
Date
Role
Action
Shares
Amount
Of holding
28 Feb 2017
EVP, Global Chief Med. Off.
Sold, plan not stated
30,000
$739.13K
30.6%
7 Feb 2017
EVP, Global Chief Med. Off.
Sold, plan not stated
80,783
$2.04M
51.6%
10 May 2016
EVP, Global Chief Med. Off.
Sold, plan not stated
80,000
$1.77M
34.7%
21 Nov 2013
EVP, Global Chief Med. Off.
Sold, plan not stated
138,850
$1.67M
62.9%
4 decisions on file.